BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12369667)

  • 1. Contrast-enhanced Doppler perfusion index: clinical and experimental evaluation.
    Ramnarine KV; Leen E; Oppo K; Angerson WJ; McArdle CS
    J Ultrasound Med; 2002 Oct; 21(10):1121-9. PubMed ID: 12369667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved characterisation of focal liver tumours: dynamic power Doppler imaging using NC100100 echo-enhancer.
    Ramnarine KV; Kyriakopoulou K; Gordon P; McDicken NW; McArdle CS; Leen E
    Eur J Ultrasound; 2000 May; 11(2):95-104. PubMed ID: 10781657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of global liver blood flow with quantitative dynamic contrast-enhanced ultrasound.
    Gauthier TP; Wasan HS; Muhammad A; Owen DR; Leen EL
    J Ultrasound Med; 2011 Mar; 30(3):379-85. PubMed ID: 21357560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quantification of hepatic arterial and portal venous flow using ultrasound contrast agents for early detection of liver metastases of colorectal cancers].
    Kissel A; Rixe O; Methlin A; Nabet M; Tranquart F; Rubini B; Jafaar S; Gaucher H
    J Radiol; 2001 Nov; 82(11):1621-5. PubMed ID: 11894547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrelationship between liver hemodynamics and tumor metabolism in liver metastases: diagnostic value of Doppler perfusion index revisited.
    Alicioglu B; Sarikaya A; Bulakbasi N
    Prague Med Rep; 2013; 114(2):103-12. PubMed ID: 23777801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast media-enhanced power Doppler sonography for evaluation of hemangiomas and malignant tumors in the liver.
    Karabacakoglu A; Karakose S; Cil AS; Kaya A
    J Gastroenterol Hepatol; 2003 Jan; 18(1):92-8. PubMed ID: 12519230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic perfusion changes in patients with liver metastases: comparison with those patients with cirrhosis.
    Leen E; Goldberg JA; Anderson JR; Robertson J; Moule B; Cooke TG; McArdle CS
    Gut; 1993 Apr; 34(4):554-7. PubMed ID: 8491406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nature of Doppler perfusion index changes in patients with colorectal cancer liver metastases.
    Kopljar M; Brkljacic B; Doko M; Horzic M
    J Ultrasound Med; 2004 Oct; 23(10):1295-300. PubMed ID: 15448318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Centrifugal (inside-out) enhancement of liver hemangiomas: a possible atypical appearance on contrast-enhanced US.
    Bartolotta TV; Taibbi A; Galia M; Lo Re G; La Grutta L; Grassi R; Midiri M
    Eur J Radiol; 2007 Dec; 64(3):447-55. PubMed ID: 17433596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Image-directed Doppler ultrasonography: a novel technique for the diagnosis of colorectal liver metastases.
    Leen E; Goldberg JA; Robertson J; Angerson WJ; Sutherland GR; Cooke TG; McArdle CS
    J Clin Ultrasound; 1993 May; 21(4):221-30. PubMed ID: 8478454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced power Doppler sonography improves the differential diagnosis of liver lesions.
    Strobel D; Hoefer A; Martus P; Hahn EG; Becker D
    Int J Colorectal Dis; 2001 Aug; 16(4):247-56. PubMed ID: 11515685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doppler sonographic evaluation of hemodynamic changes in colorectal liver metastases relative to liver size.
    Oktar SO; YĆ¼cel C; Demirogullari T; Uner A; Benekli M; Erbas G; Ozdemir H
    J Ultrasound Med; 2006 May; 25(5):575-82. PubMed ID: 16632780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascularization of liver tumors - preliminary results with Coded Harmonic Angio (CHA), phase inversion imaging, 3D power Doppler and contrast medium-enhanced B-flow with second generation contrast agent (Optison).
    Jung EM; Kubale R; Jungius KP; Jung W; Lenhart M; Clevert DA
    Clin Hemorheol Microcirc; 2006; 34(4):483-97. PubMed ID: 16687788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis.
    Wilson SR; Burns PN; Muradali D; Wilson JA; Lai X
    Radiology; 2000 Apr; 215(1):153-61. PubMed ID: 10751481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of hepatic metastases using duplex/color Doppler sonography.
    Leen E; Goldberg JA; Robertson J; Sutherland GR; Hemingway DM; Cooke TG; McArdle CS
    Ann Surg; 1991 Nov; 214(5):599-604. PubMed ID: 1953113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced color flows in hepatic tumors.
    Yang CC; Chen CH; Yeh YH
    Hepatogastroenterology; 2002; 49(48):1506-9. PubMed ID: 12397719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of contrast enhancement.
    Derchi LE; Martinoli C; Pretolesi F; Crespi G; Buccicardi D
    Eur Radiol; 1999; 9 Suppl 3():S372-6. PubMed ID: 10602932
    [No Abstract]   [Full Text] [Related]  

  • 19. Significance of duplex/colour Doppler sonography in hepatic arterial chemotherapy for patients with liver metastases from colorectal carcinoma.
    Guadagni S; Pizzutilli A; Mancini E; Varrone A; Palumbo G; Amicucci G; Perri S; Deraco M; Fiorentini G
    Eur J Surg Oncol; 2000 Jun; 26(4):381-6. PubMed ID: 10873360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound imaging of flow patterns in liver metastases from colorectal cancer.
    Rafaelsen SR; Solvig J
    Scand J Gastroenterol; 2004 Aug; 39(8):761-5. PubMed ID: 15513362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.